当前位置:首页 - 行情中心 - 康泰医学(300869) - 财务分析

康泰医学

(300869)

  

流通市值:23.53亿  总市值:35.84亿
流通股本:2.64亿   总股本:4.02亿

康泰医学(300869)财务分析

利润表
报告期2026-09-302026-06-302026-03-312025-12-31
营业总收入353,739,898.59225,877,603.09100,279,216.75468,004,884.41
营业总成本394,728,383.53255,161,799.97114,012,396.72496,009,962.87
其他经营收益
营业利润-60,148,562.71-51,222,992.64-8,832,683.51-26,332,877.65
利润总额-59,129,579.58-50,614,586-8,711,406.84-26,885,939.41
净利润-57,282,452.5-49,267,983.28-8,241,769.96-24,423,861.05
每股收益
其他综合收益-1,931,421.5-1,472,891.17-806,737.63-625,845.49
综合收益总额-59,213,874-50,740,874.45-9,048,507.59-25,049,706.54
资产负债表
报告期2026-09-302026-06-302026-03-312025-12-31
流动资产:
流动资产合计2,154,683,377.352,217,124,908.322,369,024,751.222,343,751,054.89
非流动资产:
非流动资产合计416,753,387.56421,658,045.97425,337,879.64427,441,144.35
资产总计2,571,436,764.912,638,782,954.292,794,362,630.862,771,192,199.24
流动负债:
流动负债合计126,996,914.81181,510,388.36303,818,806.5279,496,188.04
非流动负债:
非流动负债合计770,477,760.1774,838,555.66766,438,880.62758,546,399.26
负债合计897,474,674.91956,348,944.021,070,257,687.121,038,042,587.3
所有者权益(或股东权益):
归属于母公司股东权益合计1,673,962,0901,682,434,010.271,724,104,943.741,733,149,611.94
股东权益合计1,673,962,0901,682,434,010.271,724,104,943.741,733,149,611.94
负债和股东权益合计2,571,436,764.912,638,782,954.292,794,362,630.862,771,192,199.24
现金流量表
报告期2026-09-302026-06-302026-03-312025-12-31
经营活动产生的现金流量:
经营活动现金流入小计393,298,272.81266,459,564.58131,965,584.72522,290,346.6
经营活动现金流出小计385,656,078.9233,019,698.96105,338,310.05500,002,903.28
经营活动产生的现金流量净额7,642,193.9133,439,865.6226,627,274.6722,287,443.32
投资活动产生的现金流量:
投资活动现金流入小计2,549,223,510.162,142,636,433.57836,484,694.584,079,616,112.18
投资活动现金流出小计3,234,770,647.091,931,553,238.58798,803,385.643,851,827,469.18
投资活动产生的现金流量净额-685,547,136.93211,083,194.9937,681,308.94227,788,643
筹资活动产生的现金流量:
筹资活动现金流入小计25,000,00025,000,00025,000,000297,058,194.44
筹资活动现金流出小计211,396,117.58160,477,998.2817,405,212.72233,537,566.44
筹资活动产生的现金流量净额-186,396,117.58-135,477,998.287,594,787.2863,520,628
汇率变动对现金及现金等价物的影响-38,352,680.99-27,328,087.9-13,346,067.85-15,181,674.71
现金及现金等价物净增加额-902,653,741.5981,716,974.4358,557,303.04298,415,039.61
期末现金及现金等价物余额80,069,069.51,064,439,785.521,041,280,114.13982,722,811.09
补充资料:
现金及现金等价物的净增加额-81,716,974.43-298,415,039.61
TOP↑